A nerdy physicist with a love for cosmetics. His words. The rest of the industry just calls him the CEO.
Aurelian Lis sits at the top of Dermalogica, the professional skin-care brand tucked inside Unilever Prestige, and he is not embarrassed by the word "nerdy." He uses it about himself. A physicist by training, a cosmetics lifer by choice, he runs a company whose product is partly chemistry and partly the feeling you get when a therapist's hands work over your face for twenty minutes. Most CEOs would pick one of those to talk about. Lis insists on both.
His thesis is contrarian for an industry addicted to novelty: trust beats newness. "You can actually be more innovative with a brand that's got trust and a history than with a new brand," he says. Dermalogica has decades of loyalty banked with skin therapists and the clients who follow them. Lis treats that loyalty not as a legacy to protect but as a runway to build on - a base stable enough to experiment from without falling over.
So he experiments. Under Lis, Dermalogica went from one or two major innovations a year to a commitment of at least four. He pushed UK and US launches to land at the same time, because therapists asked why a product would appear on one continent months before the other. He brought back the idea that retail should feel like theatre - that a counter is a stage, not a shelf. The physicist runs the place like a lab, and the lab happens to sell hope in a jar.
Ask him what drew him to skin and he doesn't reach for marketing language. "Skincare brings science and emotion together more than any category," he says. It is the line that explains his whole career. The molecules have to work. The experience has to move you. A serum that does the first without the second is a chemistry experiment; one that does the second without the first is a candle. Lis wants the rare thing that does both, and he has spent twenty-plus years chasing it across continents and companies.
He is open about the detour. There were years in the make-up world, years that taught him merchandising, digital, and how to make a brand feel alive on a shop floor. But skin is where he started and where he returned. "I may have spent a few years in the make-up world," he says, "but before that I had my own skincare company, and having studied physics, I've always loved the scientific side of skincare." For Lis, Dermalogica wasn't a new job. It was a homecoming.
Start with the physics. A first-class honours degree from St. Peter's College, Oxford, is not where most beauty executives begin. It gave Lis the habit that shows up in every chapter after: treat the world as a set of testable claims, then test them. He carried that into an MBA at INSEAD, and from there into the business of selling things to people who care how they look.
His early career ran through Unilever PLC - strategy, operations, sales - across names like Elizabeth Arden, Cerruti, and Lagerfeld. Then a sharp left turn into the internet's first gold rush: Chief Operating Officer of Commerce at dELiA*s Corp., where he ran five e-commerce sites and helped steer the teen-fashion company through a $100 million IPO. He learned digital before digital was a department.
Then he bet on himself. Lis co-founded PRESCRIBEDsolutions, a customized skincare line sold through the offices of dermatologists and plastic surgeons - skincare tailored to the individual, distributed by the people patients already trusted. In 2009 it was acquired by a unit of Ferndale Pharma Group. Founder, builder, seller. He had done the whole arc before most executives get a P&L.
The make-up chapter came next, and it was loud. For roughly five years he ran Benefit Cosmetics' Americas business as general manager, and the numbers got big: the division quadrupled to around $500 million. He launched They're Real, which became the best-selling prestige mascara in the country. He pushed brow services out to roughly a thousand locations. Benefit's CEO credited him with sharpening brand DNA and digital. Then, at the start of 2016, Dermalogica called, and the physicist went back to skin.
When Lis arrived in 2016, he was succeeding Stephen Kurland, who had spent 24 years with Dermalogica before retiring. That is a long shadow, and a particular kind of test. Inherit a beloved brand and you can either treat it like an heirloom - dust it, admire it, change nothing - or treat it like a living thing that has to keep growing. Lis chose growth, and reported into Vasiliki Petrou, the senior executive building Unilever's prestige portfolio.
The acceleration was deliberate. A brand that had launched one or two meaningful innovations a year was suddenly committing to four or more. Product and service got stitched tighter together, because Lis had the data to prove it mattered: pair a product with a treatment and you keep roughly two of three customers, versus roughly one in four when you sell the product alone. Loyalty, it turns out, is something you can engineer.
He also kept faith with the people who built the brand in the first place - the therapists. Dermalogica was raised on professional skin therapy, on the relationship between a trained hand and a returning client, and Lis never tried to digitize that away. He digitized around it. Same-day launches across markets, education pushed outward to a new generation, a retail floor that behaves like a stage - all of it orbiting the human core that made the brand worth buying in the first place.
Lis gave Dermalogica five operating principles, and the load-bearing one is iterate relentlessly. The premise is almost suspiciously honest for a corner office: "We're not going to get it perfect the first time." So don't try. Ship, learn, adjust, repeat - and never let the dream of a "massive end solution" delay the learning.
Its cousin is compare relentlessly: run two approaches at once and let the results choose. And then there's the move that gives away the physicist - pretotyping. Before building a new 2-ounce size of the Biolumin-C serum, his team simply faked it for three days to see if demand was real. Cheaper than a wrong guess. Faster than a focus group. It's the scientific method wearing a lab coat made of spreadsheets.
The easy thing for a beauty CEO in the 2020s is to chase reach - the biggest influencers, the widest funnel, the loudest launch. Lis went the other way. Dermalogica under him works with people who are, in his words, "really gung ho about Dermalogica" before the brand ever approaches them, so they're "talking from the heart a bit more than if they've just been introduced two weeks ago."
He takes it further. Rather than hand creators a script, Dermalogica teaches them to actually perform a treatment - on themselves, on a friend - so the content carries real technique instead of a caption. The brand turned its training expertise outward, and Lis says the results were "phenomenal."
And under all of it sits a belief that no app can replicate. "When I get a Dermalogica skin treatment," he says, "it's always surprising how just the touch I get from the Dermalogica therapist adds to the level of results - and the whole experience." The physicist who pretotypes serums still thinks the most important variable is a human hand.